Exit
Article FENIN : Le secteur du dispositif médical suit les traces de l'industrie pharmaceutique

Le secteur du dispositif médical suit les traces de l’industrie pharmaceutique

L’évolution du contexte réglementaire dans l’industrie de la santé a été constante, surtout au cours des trois dernières années. On peut le voir par l’approbation du Code d’éthique FENIN (Fédération espagnole des entreprises du dispositif médical), le 20 décembre 2016. La FENIN intègre désormais les exigences du MEDTECH (Association européenne du dispositif médical) dans sa […]

Read more
Disclosure is coming

Disclosure is coming

By next June, pharmaceutical companies in EFPIA member countries, European Federation of Pharmaceutical Industries and Association, will have to disclose their transfers of value with HCPs and HCOs made in 2015. Pharmexec.com gives an assessment of the situation in Europe: are companies ready for transparency? At what cost? Read the article:

Read more
The importance of Transparency in LATAM

The importance of Transparency in LATAM

Last Tuesday April 19th BMI SYSTEM was invited to attend the official Cámara Farmacéutica de la ANDI event in Bogotá, Colombia. The event took place at the Metropolitan Club, a very emblematic place in the city. The Cámara Farmacéutica de la ANDI regroups affiliated domestic and foreign pharmaceutical companies. The main objective of this event […]

Read more
Canadian pharma companies agree for more transparency

Canadian pharma companies agree for more transparency

Facing controversy over the benefits granted to HCPs by pharmaceutical companies, ten pharma companies based in Canada have agreed to disclose the amounts paid annually to healthcare professionals and organizations. They have, on their own initiative, developed a program for improving transparency in relationships between the industry and HCPs and HCOs. More broadly, the program […]

Read more
Industry and Patients: An Evolving Partnership

Industry and Patients: An Evolving Partnership

Jane Griffiths, Company Group Chairman of Janssen EMEA, explains how the relationship between the industry and patients is evolving. Source: PharmExec To her, pharmaceutical companies are more than ever patient-centric. They are developing solutions and processes to improve interactions with patients. One way this is being done is through greater transparency, with the disclosure of […]

Read more
Final steps before first disclosure

Final steps before first disclosure

Pharmaceutical companies in Europe have spent almost two years preparing for the first disclosure of transfers of value, after the publication of the new Code of Ethics of EFPIA regulating transparency in the sector. Here are a few steps worth noticing: Change and the timeframe for adaptation have represented great challenges for pharma companies. The […]

Read more
L'essor de la e-santé

Rising of Digital Healthcare

In November 2015, GP Bullhound published an independent technology research report [1] on digital healthcare, presenting the main challenges faced by the healthcare industry and the solutions brought by digital technologies. The study defines digital healthcare as “the delivery of health services (e.g. consultations, advice, diagnostics, treatment) via digital means or the enhancement of physically […]

Read more

Transparency Rises in Asia

The 5th Asia Pacific Pharmaceutical Compliance Congress, which took place in Manilla, Philippines, on 17th – 18th August 2015, was a good opportunity to sum up the situation regarding compliance and transparency in this region. A growing life sciences industry The Asia Pacific region is geographically immense and culturally, economically and politically diverse. Many countries […]

Read more

Introducing the EFPIA Disclosure Code

Find out more about the EFPIA Disclosure Code:

Read more

Practical implications of disclosure requirements for German based pharmaceutical companies

      GÖRG and BMI SYSTEM are delighted to invite you to a free seminar entitled: “Practical implications of disclosure requirements for German based pharmaceutical companies”   Date: Thursday 4 December 2014 Time: from 8.30 a.m. to 12 a.m. Venue: GÖRG, Kennedyplatz 2, 50679 Köln. Access by car: Urbanstraße 1, 50679 Köln     […]

Read more
Close
Go top